JPMorgan Chase & Co. Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its price target dropped by stock analysts at JPMorgan Chase & Co. from $95.00 to $92.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential downside of 6.58% from the company’s previous close.

Several other analysts also recently commented on CLX. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. Citigroup lowered their price objective on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Royal Bank Of Canada dropped their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $91.00 target price on shares of Clorox in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $103.47.

Clorox Stock Up 1.6%

Shares of CLX stock traded up $1.53 during mid-day trading on Thursday, reaching $98.48. 1,399,681 shares of the company’s stock traded hands, compared to its average volume of 2,549,035. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The company’s 50-day moving average price is $94.38 and its 200-day moving average price is $104.07. The company has a market cap of $11.91 billion, a P/E ratio of 15.99, a P/E/G ratio of 0.45 and a beta of 0.54. Clorox has a 12 month low of $84.70 and a 12 month high of $132.03.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the firm posted $1.45 earnings per share. The business’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities analysts expect that Clorox will post 5.52 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.63% of the stock is owned by company insiders.

Institutional Trading of Clorox

Institutional investors and hedge funds have recently made changes to their positions in the business. Darwin Wealth Management LLC bought a new position in shares of Clorox in the second quarter worth about $29,000. Caitlin John LLC lifted its holdings in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after buying an additional 253 shares in the last quarter. Root Financial Partners LLC boosted its position in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after buying an additional 145 shares during the period. Vision Financial Markets LLC grew its stake in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares in the last quarter. Finally, Western Wealth Management LLC purchased a new position in shares of Clorox during the first quarter worth approximately $35,000. 78.53% of the stock is currently owned by institutional investors.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.